FDA’s Change Of Heart On Vytorin Ads
This article was originally published in The Pink Sheet Daily
Executive Summary
Although the campaign had been running for years with no problems, FDA instructed Merck/Schering-Plough to revise the Vytorin DTC ads even as the agency publicly affirmed the utility of the drug.